GL
ALT icon

Gerber LLC’s Altimmune ALT Stock Holding History

Gerber LLC’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Hold
0
– -$2.31M – 98
2026
Q1 		– Hold
0
– – – 14

Other funds holding ALT

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BWCS
Beirne Wealth Consulting Services Shelton, Connecticut $503M AUM 27.98% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BWM
Brown Wealth Management Naperville, Illinois $447M AUM 16.94% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
SFWA
Summit Financial Wealth Advisors Lafayette, Louisiana $782M AUM 24.35% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

Gerber LLC's ALT Position: Q3 2025 in Review

Gerber LLC sold out of Altimmune (ALT) in Q3 2025, closing a stake of 206,778 shares — an estimated $800K sold.

Gerber LLC first reported a position in ALT in Q4 2023 and held it in 7 quarters. The position peaked at $2.88M in Q4 2023. 158 funds tracked by Wall St. Rank hold ALT as of Q3 2025.

  • Gerber LLC reported no remaining Altimmune position as of Q3 2025 after selling out during the quarter.
  • Gerber LLC sold 206,778 Altimmune shares in Q3 2025, an estimated $800K.
  • Gerber LLC first reported a position in Altimmune in Q4 2023 and held it in 7 quarters.
  • Gerber LLC's Altimmune position peaked at $2.88M in Q4 2023.
  • 158 funds tracked by Wall St. Rank held Altimmune as of Q3 2025.

Based on Gerber LLC's 13F filing for Q3 2025, filed 28 Oct 2025.